Medical male circumcision lowers heterosexual HIV risk by about 60%

Three randomized trials found medical male circumcision reduces heterosexual HIV acquisition by about 60%, and WHO/UNAIDS recommend it — a documented health benefit that distinguishes it from female genital mutilation, which WHO says has "no health benefits".

The number

From three randomized controlled trials, medical male circumcision produced "an estimated 60% lower incidence of heterosexually acquired HIV infection in circumcised men" — a benefit strong enough that WHO/UNAIDS recommend it. ^[1]

What it does and doesn't establish

This documented health benefit is the core reason health authorities classify male circumcision differently from female genital mutilation, which WHO says has "no health benefits". The infant-consent debate is legitimate; the "equivalent to FGM" claim is not. Full context: is male circumcision genital mutilation?

Sources

1 source · all archived at publication

[1]Voluntary Medical Male Circumcision as an Intervention for HIV Prevention · World Health Organization / National Academies archived ↗

By The Fieldnote Desk · How we verify · Corrections